Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Adatanserin Hcl
2. Wy-50324 Hcl
3. 144966-96-1
4. Adatanserin Hydrochloride [usan]
5. Wy 50324 Hcl
6. Wy-50324-hcl
7. 48bx75b06d
8. N-(2-(4-(2-pyrimidinyl)-1-piperazinyl)ethyl)-1-adamantanecarboxamide Monohydrochloride
9. Adatanserin Hydrochloride (usan)
10. Tricyclo(3.3.1.1(sup 3,7))decane-1-carboxamide, N-(2-(4-(2-pyrimidinyl)-1-piperazinyl)ethyl)-, Monohydrochloride
11. Unii-48bx75b06d
12. Schembl120908
13. Way-seb-324
14. Chembl2107510
15. Dtxsid60162855
16. Seb-324
17. Bdbm50544115
18. D02767
19. Q27259136
20. N-[2-(4-pyrimidin-2-ylpiperazin-1-yl)ethyl]adamantane-1-carboxamide;hydrochloride
Molecular Weight | 406.0 g/mol |
---|---|
Molecular Formula | C21H32ClN5O |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 5 |
Exact Mass | 405.2295384 g/mol |
Monoisotopic Mass | 405.2295384 g/mol |
Topological Polar Surface Area | 61.4 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 497 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?